Global HMO Infant Formula Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global HMO Infant Formula market size will reach 4,486.38 Million USD in 2025 and is projected to reach 8,984.74 Million USD by 2032, with a CAGR of 10.43% (2025-2032). Notably, the China HMO Infant Formula market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
HMO (Human Milk Oligosaccharide) Infant Formula is a type of infant nutrition designed to closely mimic the composition of human breast milk by incorporating oligosaccharides, which are complex sugars naturally found in human milk. These HMOs play a vital role in promoting gut health and immune function by acting as prebiotics, helping to nourish beneficial gut bacteria and support the development of the infant＇s immune system. Since HMOs are not found in significant amounts in traditional infant formulas, their inclusion in HMO-enhanced formulas aims to offer a closer alternative to breast milk for infants who are not breastfed. HMO Infant Formula is often recommended for infants with specific dietary needs, as it may help improve digestion, reduce the risk of infections, and promote overall health during early development.
The major global manufacturers of HMO Infant Formula include Abbott, Mead Johnson（Reckitt）, Nestlé（Wyeth Nutrition）, Danone (Aptamil), FrieslandCampina (Friso), Biostime, Yili Group (Ausnutria Dairy), etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of HMO Infant Formula. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global HMO Infant Formula market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the HMO Infant Formula market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of HMO Infant Formula industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of HMO Infant Formula Include:
Abbott
Mead Johnson（Reckitt）
Nestlé（Wyeth Nutrition）
Danone (Aptamil)
FrieslandCampina (Friso)
Biostime
Yili Group (Ausnutria Dairy)
HMO Infant Formula Product Segment Include:
2＇-Fucosyllactose (2＇-FL)
Others
HMO Infant Formula Product Application Include:
Online Channel
Specialty Store
Supermarket
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global HMO Infant Formula Industry PESTEL Analysis
Chapter 3: Global HMO Infant Formula Industry Porter's Five Forces Analysis
Chapter 4: Global HMO Infant Formula Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global HMO Infant Formula Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global HMO Infant Formula Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, HMO Infant Formula Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global HMO Infant Formula market size will reach 4,486.38 Million USD in 2025 and is projected to reach 8,984.74 Million USD by 2032, with a CAGR of 10.43% (2025-2032). Notably, the China HMO Infant Formula market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
HMO (Human Milk Oligosaccharide) Infant Formula is a type of infant nutrition designed to closely mimic the composition of human breast milk by incorporating oligosaccharides, which are complex sugars naturally found in human milk. These HMOs play a vital role in promoting gut health and immune function by acting as prebiotics, helping to nourish beneficial gut bacteria and support the development of the infant＇s immune system. Since HMOs are not found in significant amounts in traditional infant formulas, their inclusion in HMO-enhanced formulas aims to offer a closer alternative to breast milk for infants who are not breastfed. HMO Infant Formula is often recommended for infants with specific dietary needs, as it may help improve digestion, reduce the risk of infections, and promote overall health during early development.
The major global manufacturers of HMO Infant Formula include Abbott, Mead Johnson（Reckitt）, Nestlé（Wyeth Nutrition）, Danone (Aptamil), FrieslandCampina (Friso), Biostime, Yili Group (Ausnutria Dairy), etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of HMO Infant Formula. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global HMO Infant Formula market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the HMO Infant Formula market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of HMO Infant Formula industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of HMO Infant Formula Include:
Abbott
Mead Johnson（Reckitt）
Nestlé（Wyeth Nutrition）
Danone (Aptamil)
FrieslandCampina (Friso)
Biostime
Yili Group (Ausnutria Dairy)
HMO Infant Formula Product Segment Include:
2＇-Fucosyllactose (2＇-FL)
Others
HMO Infant Formula Product Application Include:
Online Channel
Specialty Store
Supermarket
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global HMO Infant Formula Industry PESTEL Analysis
Chapter 3: Global HMO Infant Formula Industry Porter's Five Forces Analysis
Chapter 4: Global HMO Infant Formula Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global HMO Infant Formula Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global HMO Infant Formula Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, HMO Infant Formula Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 HMO Infant Formula Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 HMO Infant Formula Product by Type
- 1.2.1 2＇-Fucosyllactose (2＇-FL)
- 1.2.2 Others
- 1.3 HMO Infant Formula Product by Application
- 1.3.1 Online Channel
- 1.3.2 Specialty Store
- 1.3.3 Supermarket
- 1.3.4 Others
- 1.4 Global HMO Infant Formula Market Revenue and Sales Analysis
- 1.4.1 Global HMO Infant Formula Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global HMO Infant Formula Sales Market Size Analysis (2020-2032)
- 1.4.3 Global HMO Infant Formula Market Sales Price Trend Analysis (2020-2032)
- 1.5 HMO Infant Formula Market Development Status and Trends
- 1.5.1 HMO Infant Formula Industry Development Status Analysis
- 1.5.2 HMO Infant Formula Industry Development Trends Analysis
- 2 HMO Infant Formula Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 HMO Infant Formula Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global HMO Infant Formula Market Analysis by Country
- 4.1 Global HMO Infant Formula Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global HMO Infant Formula Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global HMO Infant Formula Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global HMO Infant Formula Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global HMO Infant Formula Market Sales and Market Share by Country (2020-2025)
- 4.2.2 Global HMO Infant Formula Market Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa HMO Infant Formula Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global HMO Infant Formula Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global HMO Infant Formula Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global HMO Infant Formula Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global HMO Infant Formula Average Sales Price by Manufacturers (2021-2025)
- 5.2 HMO Infant Formula Competitive Landscape Analysis and Market Dynamic
- 5.2.1 HMO Infant Formula Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 HMO Infant Formula Market Analysis by Type
- 6.1 Global HMO Infant Formula Market Revenue Analysis by Type
- 6.1.1 Global HMO Infant Formula Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global HMO Infant Formula Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global HMO Infant Formula Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global HMO Infant Formula Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Abbott
- 7.1.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Abbott HMO Infant Formula Product Portfolio
- 7.1.3 Abbott HMO Infant Formula Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Mead Johnson（Reckitt）
- 7.2.1 Mead Johnson（Reckitt） Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Mead Johnson（Reckitt） HMO Infant Formula Product Portfolio
- 7.2.3 Mead Johnson（Reckitt） HMO Infant Formula Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Nestlé（Wyeth Nutrition）
- 7.3.1 Nestlé（Wyeth Nutrition） Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Nestlé（Wyeth Nutrition） HMO Infant Formula Product Portfolio
- 7.3.3 Nestlé（Wyeth Nutrition） HMO Infant Formula Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Danone (Aptamil)
- 7.4.1 Danone (Aptamil) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Danone (Aptamil) HMO Infant Formula Product Portfolio
- 7.4.3 Danone (Aptamil) HMO Infant Formula Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 FrieslandCampina (Friso)
- 7.5.1 FrieslandCampina (Friso) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 FrieslandCampina (Friso) HMO Infant Formula Product Portfolio
- 7.5.3 FrieslandCampina (Friso) HMO Infant Formula Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Biostime
- 7.6.1 Biostime Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Biostime HMO Infant Formula Product Portfolio
- 7.6.3 Biostime HMO Infant Formula Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Yili Group (Ausnutria Dairy)
- 7.7.1 Yili Group (Ausnutria Dairy) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Yili Group (Ausnutria Dairy) HMO Infant Formula Product Portfolio
- 7.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 HMO Infant Formula Industry Chain Analysis
- 8.2 HMO Infant Formula Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 HMO Infant Formula Product Downstream Application Analysis
- 8.3.1 Global HMO Infant Formula Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global HMO Infant Formula Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global HMO Infant Formula Sales and Forecast Analysis by Application (2020-2032)
- 8.4 HMO Infant Formula Typical Downstream Customers
- 8.5 HMO Infant Formula Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
